Xiang Zhang, PhD
Disclosures: Nothing to disclose - 04/14/2022

Dr. Xiang Zhang obtained his Ph.D. degree from Columbia University in 2006, and did his postdoctoral training at Memorial Sloan Kettering Cancer Center from 2006 to 2011. He was then recruited to the Breast Center of Baylor College of Medicine as a McNair Scholar, and is now the William T. Butler Endowed Professor and interim director of Breast Center. His lab focuses on metastatic breast cancer, and has made seminal contributions in two areas: 1) bone metastasis and 2) tumor immunology and immunotherapies. Dr. Zhang is the first or corresponding author of over 30 papers published in journals including Cell, Nature, Cancer Cell, Nature Cell Biology, Developmental Cell, Nature Cancer, Nature Communications, Genes and Development, PNAS, Genome Research and MCB. He also co-authored another 50 papers published in Cell, Nature, Cancer Cell, Nature Medicine and etc. His awards include “Thesis with Distinction” by Columbia University (2006), the McNair Scholarship by Baylor College of Medicine (2011), Pathway to Independence Award by NCI (2010-2014), DoD BCRP Era of Hope Scholarship (2016), Excellent in Research Award of MCB, BCM (2016), Theresa Foundation Leadership Award (2016), and Susan G. Komen Career Catalyst Award (2014-2017), Michael E. DeBakey Award for Excellence in Research, BCM (2018), Sue Eccles Young Investigator Award by the Metastasis Research Society (2018), and Laura Zisken Award of Translational Breast Cancer Research (2020). He is a co-director of the annual Metastatic Breast Cancer Conference. He is an ad hoc reviewer of Nature, Science, Cell, Nature Medicine, Nature Cancer, Nature Cell Biology, Nature Communications, Cancer Cell, Cell Stem Cell, Cell Reports, and many other journals, and is an active member of American Association of Cancer Research (since 2012), Metastasis Research Society (since 2015), and American Association of Immunology (since 2016).